Use of glucosidase inhibitors for therapy of mucovisidosis
US7973054B2 · kind B2 · utility
4Cited by
2References
4Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 5, 2004 |
| Grant date | Jul 5, 2011 |
| Priority date | — |
| Expiry date | Mar 21, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method provides for the use of glycosidase inhibitors selected from compounds of general formula (1), wherein R1 represents a CH3 group, or CH2OH, R2 represents H or an alkyl group having 1-5 carbon atoms, or R1 and R2 together form a group having formula (II), with carbon in position (a) and nitrogen of formula (I) mentioned above, for the preparation of a medicament used to treat mucovisidosis. A corresponding product is also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.